← Compounds

Oxytocin

peptide · headlineFDA-approved

Binds to oxytocin receptors (OXTR) in the uterus and brain

Summary

Oxytocin is a nonapeptide hormone that promotes uterine contraction, lactation, and emotional bonding. Intranasal oxytocin is under investigation for its effects on social cognition, emotional regulation, and conditions like autism and anxiety. It modulates brain circuits related to trust, fear, and empathy.

How it works

  • Binds to oxytocin receptors (OXTR) in the uterus and brain
  • Triggers intracellular calcium release, causing muscle contraction
  • Activates regions of the brain linked to empathy, trust, and bonding
  • Modulates social cognition and fear response in the amygdala

Dosing

  • unit: IU
    low dose: 12
    frequency: Varies; often 2–3 times daily for behavioral use
    high dose: 48
    standard dose: 24
    administration route: Intranasal

Cycling

  • Apply 1–2 sprays per nostril up to 3x daily. Use in 5-on/2-off cycles or as needed for social and emotional regulation.

Side effects

common: ["Nasal irritation and discomfort (14% in trials)","Headache (10%), dry mouth, runny nose","Burning sensation in nose (10%), lightheadedness","Irritability (9%), tiredness (7%)"]

Chemistry & PK

sequence: CYIQNCPLG
half life: 3–5 minutes in peripheral blood
degradation: Cleared rapidly via hepatic and renal enzymatic breakdown
molecular weight: 1007.19
molecular formula: C43H66N12O12S2
tissue specificity: Acts centrally in the hypothalamus and limbic system, peripherally in uterus and mammary tissue

Verified citations

2 · PubMed-checked

Legal / compounding

FDA-approved

Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.